Evidence map›Paper›PMID 42010057›Full record

ArticleNature immunology2026

BLIMP1 shapes germinal center B cell clonal diversity by gating chromatin accessibility during light-to-dark zone transition.

Godhev Kumar Manakkat Vijay, Bala Ramaswami, Steven Gierlack, Nicholas A Pease, Peter Gerges, Dianyu Chen, Kairavee Thakkar, Luis Mena Hernandez, Swapnil Keshari, Heping Xu and 4 more

Abstract read
In one paragraph

Article in Nature immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Godhev Kumar Manakkat Vijay *Center for Systems Immunology and Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0003-3833-3057
Bala Ramaswami *Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-0402-526X
Steven Gierlack *Center for Systems Immunology and Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
Nicholas A Pease *Center for Systems Immunology and Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
Peter GergesCenter for Systems Immunology and Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
Dianyu ChenKey Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China.ORCID http://orcid.org/0000-0002-4217-2279
Kairavee ThakkarDivision of Bioinformatics, Cincinnati Children's Hospital and Medical Center, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0003-1397-486X
Luis Mena HernandezCenter for Systems Immunology and Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0001-7463-2842
Swapnil KeshariCenter for Systems Immunology and Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0001-6451-9432
Heping XuKey Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China.ORCID http://orcid.org/0000-0003-2149-7004
Nathan SalomonisDivision of Bioinformatics, Cincinnati Children's Hospital and Medical Center, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0001-9689-2469
Jishnu DasCenter for Systems Immunology and Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-5747-064X
David M RothsteinDepartment of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA, USA. rothsteind@upmc.edu.ORCID http://orcid.org/0000-0002-9455-7971
Harinder SinghCenter for Systems Immunology and Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA. harinder@pitt.edu.ORCID http://orcid.org/0000-0002-6330-8526

Funding

In Vivo Detection And Mechanisms Of Regulatory B Cell Function In TransplantationR01AI114587 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROTHSTEIN, DAVID M · 2015 to 2025
$4.1M
B cell population structure in mouse and manR01AI145064 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SINGH, HARINDER · 2019 to 2022
$1.5M
NIAID NIH HHS R01 AI114587NIAID NIH HHS R01 AI145064
6 · The paper itself

Abstract

Germinal center B cell responses are defined by many positive regulators of affinity maturation, but few components that restrain clonal dominance, notably Nr4a1, are known. We reveal an unsuspected role for BLIMP1 (Prdm1)-a plasma cell determinant-as a feedback regulator of affinity maturation. Single-cell RNA and B cell receptor (BCR) sequencing showed that B cell-specific Prdm1 loss drives an exaggerated germinal center reaction with larger clones, increased somatic hypermutation and greater clonal dominance, independent of Nr4a1. Single-cell chromatin profiling with base-resolution modeling indicated that Blimp-1 represses expression of BCR-signaling genes, gating chromatin accessibility at interferon-stimulated response elements, Ets-interferon regulatory factor composite elements, nuclear factor kappa B and Oct motifs. In the absence of BLIMP1, enhanced BCR-signaling augments activities of transcription factors that promote G1-S transition during light zone (LZ) selection and fuel dark zone (DZ) expansion. Thus, BLIMP1 attenuates BCR signaling and constrains the LZ to DZ transition, fine-tuning clonal competition, thereby maintaining repertoire diversity.

Indexed as

B-LymphocytesChromatinGerminal CenterPositive Regulatory Domain I-Binding Factor 1AnimalsMiceMice, KnockoutReceptors, Antigen, B-CellSignal TransductionChromatinPositive Regulatory Domain I-Binding Factor 1Prdm1 protein, mouseReceptors, Antigen, B-Cell

Identifiers

PMID42010057
PMCPMC13226081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.